KR870000309A - 항과민성 및 항기관지경련성 n-벤즈히드릴 디아자시클로 알킬알칸 아닐리드의 제조 방법 - Google Patents

항과민성 및 항기관지경련성 n-벤즈히드릴 디아자시클로 알킬알칸 아닐리드의 제조 방법 Download PDF

Info

Publication number
KR870000309A
KR870000309A KR1019860004899A KR860004899A KR870000309A KR 870000309 A KR870000309 A KR 870000309A KR 1019860004899 A KR1019860004899 A KR 1019860004899A KR 860004899 A KR860004899 A KR 860004899A KR 870000309 A KR870000309 A KR 870000309A
Authority
KR
South Korea
Prior art keywords
benzhydryl
piperazinyl
amide
aminophenyl
alkyl
Prior art date
Application number
KR1019860004899A
Other languages
English (en)
Inventor
나르디 단태
레오나르디 아메데오
모타 지안니
카쯜라니 피에트로
Original Assignee
람베르토 앙드레오띠
레코르다티 에스 에이, 케미칼 앤드 파마세티컬 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 람베르토 앙드레오띠, 레코르다티 에스 에이, 케미칼 앤드 파마세티컬 컴페니 filed Critical 람베르토 앙드레오띠
Publication of KR870000309A publication Critical patent/KR870000309A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

내용 없음

Description

항과민성 및 항기관지경련성 N-벤즈히드릴 디아자시클로 알킬알칸 아닐리드의 제조 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. N-벤즈히드릴 피페라진(Ⅱ)을 적당한 용매 중에서 50∼100℃의 온도로 수시간 동안 하기 일반식(Ⅲ)의 아크릴로일아닐리드 유도체 또는 하기 일반식(Ⅳ)의 화합물과 반응시키고, 수득된 생성물을 분리 및 정제함을 특징으로 하는 일반식(Ⅰ)의 화합물, 그의 이 성질체 혼합물, 각 거울상 이성질체 및 약학적으로 수용 가능한 그 염의 제조방법.
    (식중, R은 수소 또는 1∼4 탄소원자를 갖는 알킬이고, A-는 1∼4 탄소원자를 갖는 직쇄 또는 측쇄 알킬이며, R1및 R2는 각각 수소, 아미노, 알킬아미노, 디알킬아미노, 알킬기에 1∼4 탄소원자를 갖는 모노 및 디(히드록시 알킬) 아미노, 모르폴리노, 피페리디노, N-알킬 피페라지노, 1,3-디티올란-2-일리덴아미노 및 N-알킬 우레이도이고, R3및 R4는 수소 또는 저급알킬이며, n은 1∼5의 숫자이다).
  2. 제1항에 있어서, 목적 생성물이 3-(4-벤즈히드릴-1-피페라지닐)-N,4-디에틸 아미노페닐 프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-(1-모르폴리노) 페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-(1-피페리디노) 페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,3-디메틸 아미노페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-디메틸 아미노페닐 프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N-메틸-N,4-디메틸 아미노페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N-(4, 비스-(2-히드록시에틸)아미노페닐 프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-디메틸 아미노페닐부티르 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-(4-메틸-1-피페라지닐) 페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-(1-이미다졸릴) 페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,3-아미노페닐 프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-아미노페닐 프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-메틸우레이도 페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-디메틸아미노페닐 부티르아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,3-메틸아미노 페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,4-메틸아미노 페닐프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,3-아미노페닐-N-메틸프로피온 아미드, 3-(4-벤즈히드릴-1-피페라지닐)-N,3-(1,2-디티올란-2-일를덴) 아미노페닐프로피온 아미드, 2-메틸-3(4-벤즈히드릴-1-피페라지닐) -N,4-디메틸아미노 페닐프로피온 아미드인 방법.
  3. 제1항에 있어서, 용매가 디메틸포름아미드, 톨루엔 또는 크실렌중에서 선택된 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860004899A 1985-06-20 1986-06-19 항과민성 및 항기관지경련성 n-벤즈히드릴 디아자시클로 알킬알칸 아닐리드의 제조 방법 KR870000309A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21225/85A IT1190375B (it) 1985-06-20 1985-06-20 N-benzidrildiazacicloalchil-alcanilidi ad attivita' antianafilattica ed antibroncospastica
IT21225/85 1985-06-20

Publications (1)

Publication Number Publication Date
KR870000309A true KR870000309A (ko) 1987-02-17

Family

ID=11178661

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860004899A KR870000309A (ko) 1985-06-20 1986-06-19 항과민성 및 항기관지경련성 n-벤즈히드릴 디아자시클로 알킬알칸 아닐리드의 제조 방법

Country Status (24)

Country Link
US (1) US4675319A (ko)
EP (1) EP0207901B1 (ko)
JP (1) JPS61293977A (ko)
KR (1) KR870000309A (ko)
CN (1) CN1011784B (ko)
AR (1) AR241591A1 (ko)
AT (1) ATE58729T1 (ko)
AU (1) AU592348B2 (ko)
CA (1) CA1269980A (ko)
DE (1) DE3675824D1 (ko)
DK (1) DK291186A (ko)
ES (1) ES8708218A1 (ko)
FI (1) FI862204A (ko)
GR (1) GR861391B (ko)
HU (1) HU198033B (ko)
IL (1) IL78804A (ko)
IT (1) IT1190375B (ko)
NO (1) NO163816C (ko)
NZ (1) NZ216547A (ko)
PH (1) PH22809A (ko)
PT (1) PT82810B (ko)
SG (1) SG7292G (ko)
TN (1) TNSN86090A1 (ko)
ZA (1) ZA863754B (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990010329A (ko) * 1997-07-16 1999-02-18 레나르트 태퀴스트 실리콘 질화물 절삭 공구 재료
KR100384241B1 (ko) * 2000-10-31 2003-05-16 (주) 기산테크 저활동성 플라즈마 이온 방전을 이용한 오존발생장치

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660160B2 (ja) * 1985-12-13 1994-08-10 テルモ株式会社 アミド誘導体およびこれを含有する抗アレルギ−剤
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
US5028610A (en) * 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
FR2614021B1 (fr) * 1987-04-14 1991-03-01 Andre Buzas Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant
US4745191A (en) * 1987-09-30 1988-05-17 American Home Products Corporation 1-((A-substituted phenyl-ω-substituted piperazinyl)alkenyl) cyclohexanol
EP0598123A4 (en) * 1991-07-19 1995-02-15 Zeria Pharm Co Ltd PIPERAZINE DERIVATIVE AND MEDICINAL PRODUCT CONTAINING THE SAME.
AU753360B2 (en) 1998-07-31 2002-10-17 Nippon Soda Co., Ltd. Phenylazole compounds, process for producing the same and drugs for hyperlipemia
MX2009003850A (es) * 2006-10-09 2009-04-23 Clariant Finance Bvi Ltd Metodo para producir alcanol amidas de acido graso.
DE102006047618B3 (de) * 2006-10-09 2007-11-15 Clariant International Limited Verfahren zur Herstellung von Bisbenzoxazolen
DE102006047617B4 (de) * 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung basischer (Meth)acrylamide
DE102006047619B4 (de) * 2006-10-09 2008-11-13 Clariant International Limited Verfahren zur Herstellung basischer Fettsäureamide
DE102006047620B4 (de) 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung tertiärer Amide von Alkylphenylcarbonsäuren
KR101079459B1 (ko) * 2007-09-14 2011-11-03 이화여자대학교 산학협력단 신규한 화합물, 이의 제조방법 및 이를 포함하는 통증억제용 조성물
DE102008017215B4 (de) * 2008-04-04 2012-08-09 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden ethylenisch ungesättigter Carbonsäuren
DE102008017214B4 (de) * 2008-04-04 2012-02-16 Clariant International Limited Kontinuierliches Verfahren zur Herstellung von Fettsäurealkanolamiden
DE102008017216B4 (de) * 2008-04-04 2013-08-14 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
DE102008017213B4 (de) * 2008-04-04 2012-08-09 Clariant International Limited Kontinuierliches Verfahren zur Herstellung von Amiden aliphatischer Hydroxycarbonsäuren
DE102008017217A1 (de) * 2008-04-04 2009-10-08 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden aromatischer Carbonsäuren
DE102008017219A1 (de) * 2008-04-04 2009-10-08 Clariant International Ltd. Verfahren zur Herstellung von Amiden in Gegenwart von überhitztem Wasser
DE102008017218B4 (de) * 2008-04-04 2011-09-22 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Amiden niederer aliphatischer Carbonsäuren
CN101429164B (zh) * 2008-11-14 2013-03-20 广西大学 左旋二苯甲基哌嗪衍生物及其制备方法
DE102009031059A1 (de) 2009-06-30 2011-01-05 Clariant International Ltd. Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
DE102009042522A1 (de) 2009-09-22 2011-04-07 Clariant International Ltd. Kontinuierliches Umesterungsverfahren
DE102009042523B4 (de) 2009-09-22 2012-02-16 Clariant International Ltd. Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
DE102010056565A1 (de) 2010-12-30 2012-07-05 Clariant International Ltd. Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
DE102010056564A1 (de) 2010-12-30 2012-07-05 Clariant International Limited Hydroxylgruppen und Estergruppen tragende Polymere und Verfahren zu ihrer Herstellung
WO2017066705A1 (en) * 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
CN114621101A (zh) * 2020-12-11 2022-06-14 李冰坚 一种3,5-二甲基-1,2-苯二胺二盐酸盐的精制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244718A (en) * 1964-02-17 1966-04-05 Biel John Hans Piperazine derivatives
NL137318C (ko) * 1964-06-09
DE2304154A1 (de) * 1973-01-29 1974-08-01 Ichthyol Ges Cordes Hermanni & Verfahren zur herstellung von substituierten piperazin- bzw. homopiperazinderivaten
JPS5070389A (ko) * 1973-10-30 1975-06-11
GB2056968A (en) * 1979-08-21 1981-03-25 Fujisawa Pharmaceutical Co Piperazine derivative, processes for the preparation thereof and pharmaceutical composition comprising the same
US4411900A (en) * 1980-01-03 1983-10-25 Fujisawa Pharmaceutical Co., Ltd. Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990010329A (ko) * 1997-07-16 1999-02-18 레나르트 태퀴스트 실리콘 질화물 절삭 공구 재료
KR100384241B1 (ko) * 2000-10-31 2003-05-16 (주) 기산테크 저활동성 플라즈마 이온 방전을 이용한 오존발생장치

Also Published As

Publication number Publication date
HUT43837A (en) 1987-12-28
DE3675824D1 (de) 1991-01-10
US4675319A (en) 1987-06-23
NO862427L (no) 1986-12-22
AU5882886A (en) 1986-12-24
NO163816C (no) 1990-07-25
ES556145A0 (es) 1987-10-01
CN86105641A (zh) 1987-04-01
IL78804A0 (en) 1986-09-30
FI862204A0 (fi) 1986-05-26
CN1011784B (zh) 1991-02-27
JPS61293977A (ja) 1986-12-24
SG7292G (en) 1992-03-20
GR861391B (en) 1986-09-16
CA1269980A (en) 1990-06-05
EP0207901B1 (en) 1990-11-28
NZ216547A (en) 1989-11-28
HU198033B (en) 1989-07-28
AR241591A1 (es) 1992-09-30
IT1190375B (it) 1988-02-16
PT82810B (pt) 1988-04-21
ATE58729T1 (de) 1990-12-15
ES8708218A1 (es) 1987-10-01
PH22809A (en) 1988-12-27
NO163816B (no) 1990-04-17
FI862204A (fi) 1986-12-21
EP0207901A1 (en) 1987-01-07
NO862427D0 (no) 1986-06-18
IL78804A (en) 1991-12-15
TNSN86090A1 (fr) 1990-01-01
DK291186D0 (da) 1986-06-20
PT82810A (en) 1986-07-01
DK291186A (da) 1986-12-21
ZA863754B (en) 1987-01-28
AU592348B2 (en) 1990-01-11
IT8521225A0 (it) 1985-06-20

Similar Documents

Publication Publication Date Title
KR870000309A (ko) 항과민성 및 항기관지경련성 n-벤즈히드릴 디아자시클로 알킬알칸 아닐리드의 제조 방법
KR840005095A (ko) 헤테로사이클릭 화합물의 제조방법
KR850004459A (ko) 인돌유도체의 제조방법
DE19882893T1 (de) Herstellung von 3-substituierten Adeninen
KR920005840A (ko) 이소티아졸 카르복실산 유도체, 이것을 유효성분으로한 벼 도열병 방지제, 및 상기 방제제를 사용한 벼 도열병 방제방법
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
IL68964A (en) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines,a process for preparing the same and their use as medicaments
KR920000741A (ko) 모르폴리노우레아 유도체
EP0318926A3 (en) Intermediates for synthesizing 5,6,7,8-tetrahydro-l-erythro-biopterin and its derivatives
KR850008166A (ko) 인돌린 및 2-인돌리논 유도체의 제조방법
DE3586424T2 (de) Diarylbuttersaeurederivat und verfahren zu dessen herstellung.
IE821872L (en) Amine derivatives.
KR850004585A (ko) 신규 아미노과니딘 유도체의 제조방법
NO177262C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, O-substituerte oximer
PT77607A (fr) Procede de preparation de derives de la piperidinedione protecteurs du myocarde presentant une activite antiarythmique
JPS5681578A (en) Novel thioalkyl amide derivative
KR830005110A (ko) 플루오렌 유도체의 제조방법
CA1241334A (en) PROCESS FOR THE PRODUCTION OF PYRROLIDONE DERIVATIVES
KR870003107A (ko) 키산틴 유도체의 제조방법
SE8501988L (sv) Iminotiazolidinderivat
KR830007595A (ko) Cns 흥분제
KR830001225A (ko) 과니딘의 헤테로싸이클 유도체의 제조방법
DE3062759D1 (en) N,n'-dialkylaminoalkylethylene diamines and process for their production
ES451067A1 (es) Un procedimiento de preparacion de derivados de fenotiazina.
KR910016692A (ko) 신규 8-술파밀메틸렌-2-아미노 테트랄린

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application